Appendix cancer epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 25: Line 25:
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
*???????????there are for acute diseases generally????
*???????????there are for acute diseases generally????
*The 5-year survival
*'''The 5-year survival'''
*'''Appendiceal carcinoid tumors'''
*'''''Appendiceal carcinoid tumors'''''
**94% localized disease
**94% localized disease
**85% regional disease
**85% regional disease
Line 32: Line 32:
**goblet cell 12.5%
**goblet cell 12.5%
**Tubular tumors are benign clinically
**Tubular tumors are benign clinically
*'''Adenocarcinoma'''  
*'''''Adenocarcinoma'''''  
**localized 95%
**localized 95%
**Distant metastasis 0%
**Distant metastasis 0%
*'''Mucinous'''  
*'''''Mucinous'''''  
**localized 80%  
**localized 80%  
**Distant metastasis 51%  
**Distant metastasis 51%  
* '''Poor prognostic factors for adenocarcinoma''' are as follows: ''advanced stage, high grade, nonmucinous histology, spread of the tumor beyond the left lower quadrant, presence of malignant cells outside of the visceral peritoneum of the appendix .''


===Age===
===Age===

Revision as of 15:36, 16 January 2019

Appendix cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Differentiating Appendix cancer from other Diseases

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

MRI

CT scan

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Appendix cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Appendix cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Appendix cancer epidemiology and demographics

CDC on Appendix cancer epidemiology and demographics

Appendix cancer epidemiology and demographics in the news

Blogs on Appendix cancer epidemiology and demographics

Directions to Hospitals Treating Appendix cancer

Risk calculators and risk factors for Appendix cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]

Overview

Epidemiology and Demographics

  • Epidemiology of appendix cancer should be discussed with respect to the major histological characteristics of tumors.
  • Prevalence, risk factors, age distribution as well as prognosis are different in two major types of apendiceal cancers.[1]
  • According to the SEER database, adenocarcinoma accounted for 58% of appendiceal tumors. [2]
  • Carcinoid tumors comprise 50-77% of appendiceal malignancies.[3]

Incidence

  • The incidence of carcinoid tumor of appendix is approximately 0.075 per 100,000 individuals worldwide.[4]
  • The incidence of adenocarcinoma of the appendix is approximately 0.2 per 100,000 individuals worldwide.[5]

Prevalence

  • Appendiceal neoplasms account for approximately 0.4% of gastrointestinal tumors.
  • The estimated prevalence of appendix cancer is approximately 0.12 cases per 100,000 individuals in the United States.[6]
  • The estimated prevalence of adenocarcinoma of the appendix is 0.2 cases per 100,000 individuals worldwide;[6] on the other hand,?????????


Case-fatality rate/Mortality rate

???????????????????????????????????????

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].
  • ???????????there are for acute diseases generally????
  • The 5-year survival
  • Appendiceal carcinoid tumors
    • 94% localized disease
    • 85% regional disease
    • 34% distant metastases
    • goblet cell 12.5%
    • Tubular tumors are benign clinically
  • Adenocarcinoma
    • localized 95%
    • Distant metastasis 0%
  • Mucinous
    • localized 80%
    • Distant metastasis 51%
  • Poor prognostic factors for adenocarcinoma are as follows: advanced stage, high grade, nonmucinous histology, spread of the tumor beyond the left lower quadrant, presence of malignant cells outside of the visceral peritoneum of the appendix .

Age

  • The incidence of apendix cancer increases with age; meanwhile, patients with carcinoid tumors are generally younger than their adenocarcinoma counterparts.
  • The median age at diagnosis is 65 years for adenocarcinoma, compared to t 32-43 years (range, 6 to 80 years) for carcinoid tumors.[7][4]
    • The patients with Tubular carcinoids are significantly younger than the patients with goblet cell carcinoids.[8]

Race

  • There is no racial predilection to appendiceal cancers.[1]

Gender

  • Generally appendiceal cancers affects men and women equally.
  • While in adenocarcinoma there is a male dominant pattern of prevalence, females are more commonly affected by appendiceal carcinoids than men; [4][5]This might be because of high incidental appendicectomies in women. Nevertheless, in the SEER database, the male to female ratio is approximately 1 to 1.[1][7][5]

References

  1. 1.0 1.1 1.2 Chapter 5: Tumours of the Appendix - IARC. https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb2/bb2-chap5.pdf Accessed on January 15, 2019
  2. Thomas RM, Sobin LH (1995). "Gastrointestinal cancer". Cancer. 75 (1 Suppl): 154–70. PMID 8000994.
  3. Syracuse DC, Perzin KH, Price JB, Wiedel PD, Mesa-Tejada R (1979). "Carcinoid tumors of the appendix. Mesoappendiceal extension and nodal metastases". Ann Surg. 190 (1): 58–63. PMC 1344458. PMID 464679.
  4. 4.0 4.1 4.2 Modlin IM, Sandor A (1997). "An analysis of 8305 cases of carcinoid tumors". Cancer. 79 (4): 813–29. PMID 9024720.
  5. 5.0 5.1 5.2 Deans GT, Spence RA (1995). "Neoplastic lesions of the appendix". Br J Surg. 82 (3): 299–306. PMID 7795991.
  6. 6.0 6.1 Turaga KK, Pappas SG, Gamblin T (2012). "Importance of histologic subtype in the staging of appendiceal tumors". Ann. Surg. Oncol. 19 (5): 1379–85. doi:10.1245/s10434-012-2238-1. PMID 22302267.
  7. 7.0 7.1 Carr NJ, McCarthy WF, Sobin LH (1995). "Epithelial noncarcinoid tumors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors". Cancer. 75 (3): 757–68. PMID 7828125.
  8. Burke AP, Sobin LH, Federspiel BH, Shekitka KM, Helwig EB (1990). "Goblet cell carcinoids and related tumors of the vermiform appendix". Am J Clin Pathol. 94 (1): 27–35. PMID 2163192.

Template:WH Template:WS